MDxHealth, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| MDxHealth, Inc. | MDXH - NASDAQ |
$13.46-$13.46 | $12.00 | $12.15 | 3.75 million ADSs | 11/4/2021 |
| Piper Sandler, Oppenheimer & Co. | ||||||
Co-Manager(s): BTIG, KBC Securities USA | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-10-13 | ||||||
MDxHealth, Inc. Quote & Chart - Click for current quote - MDXH
IPO Boutique aggregates information on public companies and private companies, such as "MDXH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About MDxHealth, Inc. (adapted from MDxHealth, Inc. prospectus):
They are a commercial-stage precision diagnostics company committed to providing non-invasive, clinically actionable and cost-effective urologic solutions to improve patient care.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a commercial-stage precision diagnostics company committed to providing non-invasive, clinically actionable and cost-effective urologic solutions to improve patient care.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "MDXH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.